Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program
The article presents the results of treatment of patients with systemic lupus erythematosus (SLE), who, due to resistance to traditional regimens, for the first time in the Russian Federation were included in the early access program of the type I interferon inhibitor – anifrolumab. Clinical data an...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2023-04-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1412 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850023562788732928 |
|---|---|
| author | I. A. Leineman R. R. Samigullina M. S. Shostak V. I. Mazurov |
| author_facet | I. A. Leineman R. R. Samigullina M. S. Shostak V. I. Mazurov |
| author_sort | I. A. Leineman |
| collection | DOAJ |
| description | The article presents the results of treatment of patients with systemic lupus erythematosus (SLE), who, due to resistance to traditional regimens, for the first time in the Russian Federation were included in the early access program of the type I interferon inhibitor – anifrolumab. Clinical data and results of instrumental examinations of a patient with SLE on the background of 6-month therapy are presented. |
| format | Article |
| id | doaj-art-a10a790e0ca0496bb090fdb810702bdf |
| institution | DOAJ |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2023-04-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-a10a790e0ca0496bb090fdb810702bdf2025-08-20T03:01:21ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2023-04-01172727610.14412/1996-7012-2023-2-72-762568Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access programI. A. Leineman0R. R. Samigullina1M. S. Shostak2V. I. Mazurov3North-Western State Medical University named after I.I. MechnikovNorth-Western State Medical University named after I.I. MechnikovNorth-Western State Medical University named after I.I. MechnikovNorth-Western State Medical University named after I.I. MechnikovThe article presents the results of treatment of patients with systemic lupus erythematosus (SLE), who, due to resistance to traditional regimens, for the first time in the Russian Federation were included in the early access program of the type I interferon inhibitor – anifrolumab. Clinical data and results of instrumental examinations of a patient with SLE on the background of 6-month therapy are presented.https://mrj.ima-press.net/mrj/article/view/1412systemic lupus erythematosusearly access programtype i interferon inhibitoranifrolumabclinical case |
| spellingShingle | I. A. Leineman R. R. Samigullina M. S. Shostak V. I. Mazurov Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program Современная ревматология systemic lupus erythematosus early access program type i interferon inhibitor anifrolumab clinical case |
| title | Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program |
| title_full | Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program |
| title_fullStr | Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program |
| title_full_unstemmed | Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program |
| title_short | Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program |
| title_sort | treatment of resistant forms of systemic lupus erythematosus with a type i interferon inhibitor in the early access program |
| topic | systemic lupus erythematosus early access program type i interferon inhibitor anifrolumab clinical case |
| url | https://mrj.ima-press.net/mrj/article/view/1412 |
| work_keys_str_mv | AT ialeineman treatmentofresistantformsofsystemiclupuserythematosuswithatypeiinterferoninhibitorintheearlyaccessprogram AT rrsamigullina treatmentofresistantformsofsystemiclupuserythematosuswithatypeiinterferoninhibitorintheearlyaccessprogram AT msshostak treatmentofresistantformsofsystemiclupuserythematosuswithatypeiinterferoninhibitorintheearlyaccessprogram AT vimazurov treatmentofresistantformsofsystemiclupuserythematosuswithatypeiinterferoninhibitorintheearlyaccessprogram |